Potential direct and indirect effects of GLP

The GLP-1 receptor ( GLP -1R), which mediates the biological effects of the hormone with relevance for and beyond CVD, is present across many organs and tissues in humans (Figure 1 ).

Glucagon-like peptide-1 receptor agonists ( GLP-1 RAs) significantly reduce major adverse cardiovascular events in patients with and without Type 2 diabetes, offering benefits that extend beyond glycemic control. This review summarizes proposed multifactorial mechanisms underlying these effects , categorizing them into indirect and direct pathways.
Key Details About Potential Direct And Indirect Effects Of Glp 1 Receptor Agonists

Abstract Glucagon-like peptide-1 receptor agonists ( GLP -1RAs), initially developed for type 2 diabetes and obesity, have evolved into multi-organ potential therapeutics due to their pleiotropic effects beyond glycemic control. Mechanistically, GLP-1 signaling modulates immune and inflammatory pathways, regulates autophagy and pyroptosis, alleviates endoplasmic reticulum stress, and interacts ...
Background Glucagon-like peptide-1 ( GLP-1 ) is a crucial incretin hormone secreted by intestinal endocrine L cells. Given its pivotal physiological role, researchers have developed GLP-1 receptor agonists ( GLP-1 RAs) through structural modifications. These analogues display pharmacological effects similar to those of GLP-1 but with augmented stability and are regarded as an effective means of ...

The Cardiovascular Physiology of Glucagon
The review delves into the complex and controversial effects on the myocardium, addressing the debate over GLP-1 receptor expression and detailing the interplay of direct and indirect actions on cardiomyocyte metabolism, ion homeostasis, and fibrosis.
Abstract Glucagon like peptide-1 ( GLP-1 ) is an incretin secretory molecule. GLP-1 receptor agonists ( GLP -1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their attributes such as body weight loss, protection of islet β cells, promotion of islet β cell proliferation and minimal side effects . Studies have found that GLP -1R is widely distributed on pancreatic and other ...

Overview of Potential Direct And Indirect Effects Of Glp 1 Receptor Agonists
Additionally, this paper explores the potential applications of GLP-1 receptor agonists ( GLP -1RAs) in fields such as neuroprotection, anti-infection measures, the reduction of various types of ...
This review provides a comprehensive and scholarly examination of glucagon-like peptide-1 receptor ( GLP -1R) agonists , tracing their evolution from glycemic control agents in diabetes mellitus (DM) to multifaceted therapeutics with expanding ...

The Clinical Application of GLP
This review provides a comprehensive examination of the clinical pharmacological mechanisms and broad therapeutic applications of glucagon-like peptide-1 receptor agonists ( GLP -1RAs) and dual receptor agonists targeting both glucagon-like peptide-1 ...








Purpose of Review This review provides a comprehensive and scholarly examination of glucagon-like peptide-1 receptor ( GLP -1R) agonists , tracing their evolution from glycemic control agents in diabetes mellitus (DM) to multifaceted therapeutics with expanding indications in cardiovascular, renal, and metabolic health. We explore the underlying biological mechanisms, summarize clinical trial ...